Literature DB >> 16610565

Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations.

Josepha Binder1, Steve R Ommen, Bernard J Gersh, Sara L Van Driest, A Jamil Tajik, Rick A Nishimura, Michael J Ackerman.   

Abstract

OBJECTIVE: To examine the relationship among age, septal morphological subtype, and presence of hypertrophic cardiomyopathy (HCM)-associated myofilament mutations. PATIENTS AND METHODS: Comprehensive mutation analysis of the 8 HCM susceptibility genes that encode the myofilaments of the cardiac sarcomere was performed previously in 382 unrelated patients with HCM. Blinded to genotype status, we used echocardiography to characterize the left ventricular morphological features. Multivariate regression was used to assess the relationship among morphological subtypes, clinical data, and genetic variables.
RESULTS: The mean +/- SD age of the patients was 41.6+/-19.0 years, with 126 patients 50 years or older at initial diagnosis. The septal morphological subtype was sigmold in 181 (47%), reverse in 132 (35%), apical variant in 37 (10%), and neutral in 32 (8%). The HCM-associated myofilament mutations were Identified in 143 patients (37%). Multivariate analysis showed that the reverse curvature septal morphological subtype was a strong predictor of genotype-positive status (odds ratio, 21; P<.001). Overall, the yield of HCM genetic testing was 79% in the setting of reverse curvature HCM but only 8% in sigmold septal HCM.
CONCLUSION: In stark contrast to HCM in young patients, elderly patients with HCM display a predominantly sigmoid septal morphological subtype and uncommonly have perturbations of known HCM susceptibility genes. Independent of age, septal morphological subtype strongly predicts the presence or absence of HCM-associated myofilament mutations and may enable echocardiography-guided genetic testing for HCM.

Entities:  

Mesh:

Year:  2006        PMID: 16610565     DOI: 10.4065/81.4.459

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  51 in total

1.  MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors.

Authors:  Yasuo Amano; Mitsunobu Kitamura; Morimasa Takayama; Masaki Tachi; Shinichiro Kumita
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-04       Impact factor: 2.357

Review 2.  The left ventricular outflow in hypertrophic cardiomyopathy: from structure to function.

Authors:  Magdi H Yacoub; Ismail El-Hamamsy; Karim Said; Gehan Magdi; Fatma Abul Enein; Robert George; Alessandra Rossi; Iacopo Olivotto; Franco Cecchi
Journal:  J Cardiovasc Transl Res       Date:  2009-11-26       Impact factor: 4.132

3.  Eccentric apical hypertrophic cardiomyopathy unmasked by multimodality imaging: an uncommon but missed cause of out of hospital cardiac arrest.

Authors:  Eric Towe; Saurabh Sharma; Jeffrey Geske; Michael J Ackerman
Journal:  BMJ Case Rep       Date:  2015-07-06

4.  Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI.

Authors:  Kalie Y Kebed; Raed I Al Adham; Kalkidan Bishu; J Wells Askew; Kyle W Klarich; Jae K Oh; Paul R Julsrud; Thomas A Foley; James F Glockner; Rick A Nishimura; Steve R Ommen; Nandan S Anavekar
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-05       Impact factor: 2.357

5.  Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy.

Authors:  Sinead L Murphy; Jason H Anderson; Jamie D Kapplinger; Teresa M Kruisselbrink; Bernard J Gersh; Steve R Ommen; Michael J Ackerman; J Martijn Bos
Journal:  J Cardiovasc Transl Res       Date:  2016-02-25       Impact factor: 4.132

6.  Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.

Authors:  Stefan Neubauer; Paul Kolm; Carolyn Y Ho; Raymond Y Kwong; Milind Y Desai; Sarahfaye F Dolman; Evan Appelbaum; Patrice Desvigne-Nickens; John P DiMarco; Matthias G Friedrich; Nancy Geller; Andrew R Harper; Petr Jarolim; Michael Jerosch-Herold; Dong-Yun Kim; Martin S Maron; Jeanette Schulz-Menger; Stefan K Piechnik; Kate Thomson; Cheng Zhang; Hugh Watkins; William S Weintraub; Christopher M Kramer
Journal:  J Am Coll Cardiol       Date:  2019-11-12       Impact factor: 24.094

7.  Hypertrophic Cardiomyopathy Genotype Prediction Models in a Pediatric Population.

Authors:  Randa Newman; John Lynn Jefferies; Clifford Chin; Hua He; Amy Shikany; Erin M Miller; Ashley Parrott
Journal:  Pediatr Cardiol       Date:  2018-01-24       Impact factor: 1.655

8.  Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.

Authors:  Eric C Wooten; Virginia B Hebl; Matthew J Wolf; Sarah R Greytak; Nicole M Orr; Isabelle Draper; Jenna E Calvino; Navin K Kapur; Martin S Maron; Iftikhar J Kullo; Steve R Ommen; J Martijn Bos; Michael J Ackerman; Gordon S Huggins
Journal:  Circ Cardiovasc Genet       Date:  2012-12-19

9.  Hypertrophic cardiomyopathy in the Saudi Arabian population: Clinical and echocardiographic characteristics and outcome analysis.

Authors:  Waqas Ahmed; Naveed Akhtar; Odd Bech-Hanssen; Bader Al Mahdi; Talal Al Otaibi; Bahaa M Fadel
Journal:  J Saudi Heart Assoc       Date:  2013-08-20

Review 10.  Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.

Authors:  Marco Canepa; Iraklis Pozios; Pier Filippo Vianello; Pietro Ameri; Claudio Brunelli; Luigi Ferrucci; Theodore P Abraham
Journal:  Heart       Date:  2016-04-27       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.